Nplate — Total revenues
Amgen Nplate — Total revenues increased by 7.0% to $412.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.6%, from $313.00M to $412.00M. Over 3 years (FY 2022 to FY 2025), Nplate — Total revenues shows an upward trend with a 5.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing clinical adoption or expanded patient access, while a decrease may signal increased competition from biosimilars or newer therapeutic alternatives.
Detailed definition
This metric represents the total gross sales generated from the Nplate product line, a therapeutic agent used for the tr...
Peer comparison
Comparable to specialized therapeutic product revenue lines at other large-cap biotechnology firms, often benchmarked against market share in niche hematology or immunology segments.
amgn_segment_nplate_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $245.00M | $273.00M | $266.00M | $284.00M | $288.00M | $469.00M | $362.00M | $310.00M | $419.00M | $386.00M | $317.00M | $346.00M | $456.00M | $337.00M | $313.00M | $369.00M | $457.00M | $385.00M | $412.00M |
| QoQ Change | — | +11.4% | -2.6% | +6.8% | +1.4% | +62.8% | -22.8% | -14.4% | +35.2% | -7.9% | -17.9% | +9.1% | +31.8% | -26.1% | -7.1% | +17.9% | +23.8% | -15.8% | +7.0% |
| YoY Change | — | — | — | +15.9% | +5.5% | — | +36.1% | +9.2% | +45.5% | -17.7% | -12.4% | +11.6% | +8.8% | -12.7% | -1.3% | +6.6% | +0.2% | +14.2% | +31.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's nplate — total revenues?
- Amgen (AMGN) reported nplate — total revenues of $412.00M in Q1 2026.
- How has Amgen's nplate — total revenues changed year-over-year?
- Amgen's nplate — total revenues increased by 31.6% year-over-year, from $313.00M to $412.00M.
- What is the long-term trend for Amgen's nplate — total revenues?
- Over 3 years (2022 to 2025), Amgen's nplate — total revenues has grown at a 5.3% compound annual growth rate (CAGR), from $1.31B to $1.52B.
- What does nplate — total revenues mean?
- The total revenue generated from sales of the Nplate therapeutic product.